Filter
1480
Text search:
regimens
Featured
186
361
Language
Document type
849
263
207
60
39
28
18
7
4
3
1
Countries / Regions
81
51
51
37
36
30
28
27
27
24
22
22
20
20
15
14
13
13
13
12
12
11
11
10
10
9
9
8
8
8
8
8
6
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
506
229
71
69
31
18
13
Toolboxes
305
244
77
51
42
41
41
32
26
21
20
17
12
12
8
6
5
5
5
4
3
2
2
1
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure
...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
A review of prospects for existing antibiotics ad new therapeutics
Panel Recommendations
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV K-19 Tuberculosis/HIV Coinfection
Updated: September 12, 2024 Key Considerations and Recommendations
Guide; revised 15 June 2010